| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 4 |
| Forrest at al. (procyclic) | no | yes: 4 |
| Silverman et al. | no | yes: 2 |
| Pissara et al. | yes | yes: 10 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 4 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HEA4
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0000166 | nucleotide binding | 3 | 3 |
| GO:0003824 | catalytic activity | 1 | 3 |
| GO:0004127 | cytidylate kinase activity | 6 | 3 |
| GO:0005488 | binding | 1 | 3 |
| GO:0005524 | ATP binding | 5 | 3 |
| GO:0016301 | kinase activity | 4 | 3 |
| GO:0016740 | transferase activity | 2 | 3 |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 3 |
| GO:0016776 | phosphotransferase activity, phosphate group as acceptor | 4 | 3 |
| GO:0017076 | purine nucleotide binding | 4 | 3 |
| GO:0019205 | nucleobase-containing compound kinase activity | 5 | 3 |
| GO:0030554 | adenyl nucleotide binding | 5 | 3 |
| GO:0032553 | ribonucleotide binding | 3 | 3 |
| GO:0032555 | purine ribonucleotide binding | 4 | 3 |
| GO:0032559 | adenyl ribonucleotide binding | 5 | 3 |
| GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 3 |
| GO:0036094 | small molecule binding | 2 | 3 |
| GO:0043167 | ion binding | 2 | 3 |
| GO:0043168 | anion binding | 3 | 3 |
| GO:0050145 | nucleoside monophosphate kinase activity | 5 | 3 |
| GO:0097159 | organic cyclic compound binding | 2 | 3 |
| GO:0097367 | carbohydrate derivative binding | 2 | 3 |
| GO:1901265 | nucleoside phosphate binding | 3 | 3 |
| GO:1901363 | heterocyclic compound binding | 2 | 3 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 183 | 187 | PF00656 | 0.532 |
| CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.383 |
| CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.506 |
| CLV_PCSK_KEX2_1 | 169 | 171 | PF00082 | 0.516 |
| CLV_PCSK_KEX2_1 | 268 | 270 | PF00082 | 0.383 |
| CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.558 |
| CLV_PCSK_PC1ET2_1 | 169 | 171 | PF00082 | 0.516 |
| CLV_PCSK_PC1ET2_1 | 43 | 45 | PF00082 | 0.607 |
| CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.446 |
| CLV_PCSK_SKI1_1 | 126 | 130 | PF00082 | 0.379 |
| CLV_PCSK_SKI1_1 | 152 | 156 | PF00082 | 0.536 |
| CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.301 |
| CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.500 |
| CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.611 |
| CLV_PCSK_SKI1_1 | 62 | 66 | PF00082 | 0.338 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.655 |
| DOC_AGCK_PIF_1 | 136 | 141 | PF00069 | 0.380 |
| DOC_CKS1_1 | 199 | 204 | PF01111 | 0.467 |
| DOC_CKS1_1 | 249 | 254 | PF01111 | 0.293 |
| DOC_CYCLIN_yClb5_NLxxxL_5 | 154 | 163 | PF00134 | 0.328 |
| DOC_MAPK_MEF2A_6 | 51 | 60 | PF00069 | 0.435 |
| DOC_MAPK_RevD_3 | 255 | 269 | PF00069 | 0.391 |
| DOC_PP1_RVXF_1 | 124 | 131 | PF00149 | 0.400 |
| DOC_PP1_RVXF_1 | 167 | 174 | PF00149 | 0.400 |
| DOC_PP2B_LxvP_1 | 257 | 260 | PF13499 | 0.532 |
| DOC_USP7_MATH_1 | 94 | 98 | PF00917 | 0.572 |
| DOC_WW_Pin1_4 | 198 | 203 | PF00397 | 0.500 |
| DOC_WW_Pin1_4 | 248 | 253 | PF00397 | 0.381 |
| DOC_WW_Pin1_4 | 283 | 288 | PF00397 | 0.371 |
| DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.587 |
| LIG_14-3-3_CanoR_1 | 137 | 142 | PF00244 | 0.359 |
| LIG_14-3-3_CanoR_1 | 170 | 174 | PF00244 | 0.461 |
| LIG_14-3-3_CanoR_1 | 242 | 247 | PF00244 | 0.386 |
| LIG_BIR_III_2 | 122 | 126 | PF00653 | 0.475 |
| LIG_FHA_1 | 158 | 164 | PF00498 | 0.398 |
| LIG_FHA_1 | 186 | 192 | PF00498 | 0.524 |
| LIG_FHA_1 | 199 | 205 | PF00498 | 0.473 |
| LIG_FHA_1 | 222 | 228 | PF00498 | 0.529 |
| LIG_FHA_1 | 3 | 9 | PF00498 | 0.399 |
| LIG_FHA_1 | 86 | 92 | PF00498 | 0.423 |
| LIG_FHA_2 | 181 | 187 | PF00498 | 0.498 |
| LIG_FHA_2 | 213 | 219 | PF00498 | 0.415 |
| LIG_FHA_2 | 284 | 290 | PF00498 | 0.410 |
| LIG_LIR_Gen_1 | 138 | 147 | PF02991 | 0.349 |
| LIG_LIR_Gen_1 | 233 | 239 | PF02991 | 0.502 |
| LIG_LIR_Gen_1 | 29 | 37 | PF02991 | 0.386 |
| LIG_LIR_Nem_3 | 138 | 142 | PF02991 | 0.340 |
| LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.504 |
| LIG_LIR_Nem_3 | 29 | 33 | PF02991 | 0.389 |
| LIG_PDZ_Class_3 | 297 | 302 | PF00595 | 0.370 |
| LIG_SH2_CRK | 139 | 143 | PF00017 | 0.375 |
| LIG_SH2_CRK | 235 | 239 | PF00017 | 0.387 |
| LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.379 |
| LIG_SH2_STAT5 | 248 | 251 | PF00017 | 0.435 |
| LIG_SUMO_SIM_anti_2 | 160 | 168 | PF11976 | 0.312 |
| LIG_SUMO_SIM_par_1 | 160 | 168 | PF11976 | 0.312 |
| LIG_TRAF2_1 | 287 | 290 | PF00917 | 0.640 |
| LIG_TRAF2_1 | 83 | 86 | PF00917 | 0.491 |
| LIG_UBA3_1 | 163 | 169 | PF00899 | 0.301 |
| LIG_UBA3_1 | 91 | 98 | PF00899 | 0.414 |
| MOD_CDK_SPxK_1 | 248 | 254 | PF00069 | 0.374 |
| MOD_CDK_SPxxK_3 | 69 | 76 | PF00069 | 0.572 |
| MOD_CK1_1 | 72 | 78 | PF00069 | 0.411 |
| MOD_CK2_1 | 162 | 168 | PF00069 | 0.525 |
| MOD_CK2_1 | 186 | 192 | PF00069 | 0.339 |
| MOD_CK2_1 | 212 | 218 | PF00069 | 0.419 |
| MOD_CK2_1 | 283 | 289 | PF00069 | 0.599 |
| MOD_CK2_1 | 31 | 37 | PF00069 | 0.454 |
| MOD_CK2_1 | 80 | 86 | PF00069 | 0.476 |
| MOD_GlcNHglycan | 108 | 111 | PF01048 | 0.432 |
| MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.328 |
| MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.558 |
| MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.559 |
| MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.498 |
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.412 |
| MOD_GSK3_1 | 194 | 201 | PF00069 | 0.446 |
| MOD_GSK3_1 | 203 | 210 | PF00069 | 0.456 |
| MOD_GSK3_1 | 29 | 36 | PF00069 | 0.459 |
| MOD_N-GLC_1 | 157 | 162 | PF02516 | 0.337 |
| MOD_N-GLC_1 | 283 | 288 | PF02516 | 0.544 |
| MOD_NEK2_1 | 108 | 113 | PF00069 | 0.405 |
| MOD_NEK2_1 | 185 | 190 | PF00069 | 0.531 |
| MOD_NEK2_1 | 203 | 208 | PF00069 | 0.630 |
| MOD_PIKK_1 | 212 | 218 | PF00454 | 0.413 |
| MOD_PIKK_1 | 240 | 246 | PF00454 | 0.472 |
| MOD_PKA_1 | 169 | 175 | PF00069 | 0.518 |
| MOD_PKA_2 | 169 | 175 | PF00069 | 0.518 |
| MOD_Plk_2-3 | 157 | 163 | PF00069 | 0.552 |
| MOD_Plk_4 | 137 | 143 | PF00069 | 0.377 |
| MOD_Plk_4 | 162 | 168 | PF00069 | 0.467 |
| MOD_Plk_4 | 194 | 200 | PF00069 | 0.386 |
| MOD_ProDKin_1 | 198 | 204 | PF00069 | 0.492 |
| MOD_ProDKin_1 | 248 | 254 | PF00069 | 0.374 |
| MOD_ProDKin_1 | 283 | 289 | PF00069 | 0.376 |
| MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.587 |
| TRG_DiLeu_BaEn_1 | 162 | 167 | PF01217 | 0.304 |
| TRG_DiLeu_BaLyEn_6 | 199 | 204 | PF01217 | 0.553 |
| TRG_ENDOCYTIC_2 | 139 | 142 | PF00928 | 0.357 |
| TRG_ENDOCYTIC_2 | 235 | 238 | PF00928 | 0.387 |
| TRG_NES_CRM1_1 | 247 | 261 | PF08389 | 0.473 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I1G0 | Leptomonas seymouri | 78% | 100% |
| A0A0S4IKR6 | Bodo saltans | 54% | 100% |
| A0A1X0NZI5 | Trypanosomatidae | 62% | 100% |
| A0A3S7WZD1 | Leishmania donovani | 87% | 99% |
| A0A422P4M6 | Trypanosoma rangeli | 58% | 100% |
| A4I1Q0 | Leishmania infantum | 87% | 99% |
| C9ZKA2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 98% |
| E9AXT4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 99% |
| Q4Q9N7 | Leishmania major | 86% | 100% |
| V5BMH9 | Trypanosoma cruzi | 61% | 100% |